Inner and middle ear hyperbaric oxygen-induced barotrauma. | Canada Hyperbarics Skip to main content
Clinical Guideline The Laryngoscope 1997

Inner and middle ear hyperbaric oxygen-induced barotrauma.

Beuerlein M, Nelson RN, Welling DB — The Laryngoscope, 1997

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers assessed the incidence and significance of inner and middle ear barotrauma in 30 patients undergoing hyperbaric oxygen therapy, stratifying them into groups based on their ability to autoinflate their middle ear.

What They Found

They found that 91% (10 of 11) of patients unable to autoinflate suffered middle ear barotrauma, compared to 37% (7 of 19) of those who could autoinflate. A significant decrease in DPOAEs was observed in 27% of autoinflaters and 29% of noninflaters, though this was not linked to audiometry changes.

What This Means for Canadian Patients

Canadian patients undergoing hyperbaric oxygen therapy, especially those with an artificial airway or eustachian tube dysfunction, should discuss prophylactic interventions like pressure-equalizing tubes or myringotomies with their doctor. This can help prevent painful and potentially damaging ear barotrauma during treatment.

Canadian Relevance

This study does not have a direct Canadian connection.

Study Limitations

A limitation of this study is its relatively small sample size of 30 patients, which may affect the generalizability of the findings.

Was this summary helpful?

Study Details

Study Type Clinical Guideline
Category Systematic Reviews
Source Pubmed
PubMed ID 9331312
Year Published 1997
Journal The Laryngoscope
MeSH Terms Barotrauma; Case-Control Studies; Ear, Inner; Ear, Middle; Eustachian Tube; Humans; Hyperbaric Oxygenation; Incidence; Intubation, Intratracheal; Middle Ear Ventilation; Practice Guidelines as Topic; Prospective Studies

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.